Drug Shortage Report for ACT-HIB

Last updated on 2018-01-22 History
Report ID 4464
Drug Identification Number 01959034
Brand name ACT-HIB
Common or Proper name Haemophilus b Conjugate Vaccine (Tetanus Protein – Conjugate)
Company Name SANOFI PASTEUR LIMITED
Active Ingredient(s) HAEMOPHILUS INFLUENZAE TYPE B-PRP TETANUS PROTEIN
Strength(s) 10 μG 30 μG
Dosage form(s) Powder For Solution
Route of administration INTRAMUSCULAR
Packaging size 5 x 0.5 mL vials / 5 fioles de 0,5 mL
ATC code J07AG
ATC description BACTERIAL VACCINES
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2017-03-28
Actual start date 2017-03-28
Estimated end date 2017-11-15
Actual end date 2018-01-18
Shortage status Resolved
Updated date 2018-01-22
Company comments Act-Hib lot# UI880AA was released to the market on January 18, 2018.
Health Canada comments
Contact Address 1755 STEELES AVENUE WEST
TORONTO, ONTARIO
CANADA M2R 3T4
Company contact information Customer Service/Service à la clientèle: 416-667-2611 or 1-800-268-4171 Vaccine Information Service/Service d'information sur les vaccins: 416-667-2779 or 1-888-621-1146

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2018-01-22 French Compare
v9 2018-01-22 English Compare
v8 2018-01-22 French Compare
v7 2018-01-22 English Compare
v6 2017-03-29 French Compare
v5 2017-03-29 English Compare
v4 2017-03-28 French Compare
v3 2017-03-28 English Compare
v2 2017-03-28 French Compare
v1 2017-03-28 English Compare